Elsevier gives free access to content and resources via just-launched Monkeypox Information Center to accelerate fight against viral disease
New York | 15 August 2022
Online information center provides free access to the latest medical and scientific information from across Elsevier’s global research content, platforms and clinical resources
For the benefit of healthcare professionals, medical researchers, and the public, Elsevier, a leading scientific publisher and global information analytics business specializing in science and health, has today launched a Monkeypox Information Center. The hub will be continually updated and provide free access to relevant research and clinical information on the Monkeypox virus from across Elsevier’s scientific and medical journals and clinical resources for healthcare professionals. This research and health information will be freely available from Elsevier platforms and shared with the World Health Organization (WHO). In addition, the company, will contribute Monkeypox-relevant journal articles to PubMed Central, the archive of biomedical and life sciences research at the U.S. National Institutes of Health’s National Library of Medicine, for as long as the Monkeypox public health emergency is ongoing. Updated frequently, The Monkeypox Information Center will offer access to journal articles and book chapters to ensure researchers, clinicians and the public can readily discover relevant content from the rapidly growing body of literature. It will also provide a machine-readable corpus to enable use of text and data mining technologies to identify patterns and relationships in data, as countries around the world address this global public health crisis.
The Monkeypox Information Center is updated continuously with the latest research information on the virus and the disease. In addition, Monkeypox-related journal articles and book chapters are made freely available on ScienceDirect, Elsevier’s global platform of peer-reviewed scholarly literature. Around 400 journal articles were identified initially, and latest research and guidance will be added as they become available. The launch of this information center is part of Elsevier’s commitment to support the research and healthcare communities in their efforts to address public health emergencies and follows the company’s information hubs for Ebola, SARS, Zika and MERS outbreaks, and the current pandemic response continues to be supported by the existing novel coronavirus resource centre.
“The Monkeypox Information Center will support healthcare professionals, clinical researchers, and policy makers in understanding Monkeypox, so that best efforts can be made towards its prevention and treatment,” said Kumsal Bayazit, CEO, Elsevier. “To support research and healthcare communities we serve, with the public health emergency, we are providing an information center where the medical community, patients, and their caregivers can readily access the most up-to-date information.”
The Monkeypox Information Center is hosted on Elsevier Connect, the company’s public news and information website. It allows free access to content curated in consultation with Elsevier clinicians and other experts. It brings together content from the company’s journals, books, monographs and clinical information solutions as well as resources from other information providers and major health and government organizations. Also available is information typically used by practicing nurses and physicians, plus resources designed specifically for patients and their families.
The site also links to other authoritative resources, including the WHO and the U.S. Centers for Disease Control and Prevention.
About Elsevier
As a global leader in scientific information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies.
We have supported the work of our research and healthcare communities for more than 140 years. Our 9,500 employees around the world, including 2,500 technologists, are dedicated to supporting researchers, librarians, academic leaders, funders, governments, R&D-intensive companies, doctors, nurses, future healthcare professionals and educators in their critical work. Our 2,900 scientific journals and iconic reference books include the foremost titles in their fields, including Cell Press, The Lancet and Gray’s Anatomy.
Together with the Elsevier Foundation opens in new tab/window, we work in partnership with the communities we serve to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.
Elsevier is part of RELX opens in new tab/window, a global provider of information-based analytics and decision tools for professional and business customers. For more information on our work, digital solutions and content, visit www.elsevier.com.